Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,936 | 949 | 99.0% |
| Education | $177.93 | 6 | 1.0% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $7,392 | 374 | $0 (2024) |
| Janssen Biotech, Inc. | $2,051 | 126 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,120 | 74 | $0 (2024) |
| PFIZER INC. | $908.07 | 40 | $0 (2024) |
| Gilead Sciences, Inc. | $676.34 | 43 | $0 (2024) |
| Merck Sharp & Dohme LLC | $462.35 | 28 | $0 (2024) |
| Celgene Corporation | $442.09 | 35 | $0 (2023) |
| Ferring Pharmaceuticals Inc. | $371.54 | 32 | $0 (2022) |
| NESTLE HEALTHCARE NUTRITION INC. | $353.73 | 21 | $0 (2023) |
| GENZYME CORPORATION | $346.48 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,706 | 188 | ABBVIE INC. ($1,294) |
| 2023 | $3,051 | 159 | ABBVIE INC. ($1,317) |
| 2022 | $2,440 | 136 | ABBVIE INC. ($963.98) |
| 2021 | $2,387 | 138 | AbbVie Inc. ($1,145) |
| 2020 | $948.97 | 56 | AbbVie Inc. ($420.24) |
| 2019 | $1,775 | 81 | AbbVie, Inc. ($852.08) |
| 2018 | $1,784 | 96 | AbbVie, Inc. ($959.44) |
| 2017 | $2,021 | 105 | AbbVie, Inc. ($440.34) |
All Payment Transactions
959 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.53 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $14.83 | General |
| Category: GI | ||||||
| 11/26/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.81 | General |
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Immunology | ||||||
| 11/20/2024 | ABBVIE INC. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Education | In-kind items and services | $13.76 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/15/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: GI | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: Immunology | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Immunology | ||||||
| 11/04/2024 | ABBVIE INC. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $7.54 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/01/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.99 | General |
| 10/29/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,092 | 9,449 | $728,693 | $253,887 |
| 2022 | 22 | 1,241 | 18,189 | $1.1M | $421,335 |
| 2021 | 22 | 1,242 | 1,931 | $461,160 | $125,904 |
| 2020 | 19 | 833 | 973 | $296,698 | $82,676 |
All Medicare Procedures & Services
83 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3380 | Injection, vedolizumab, 1 mg | Office | 2023 | 11 | 7,500 | $262,500 | $130,719 | 49.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 105 | 106 | $112,735 | $20,198 | 17.9% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 38 | 442 | $30,940 | $14,581 | 47.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 139 | 180 | $28,800 | $14,116 | 49.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 167 | 199 | $20,497 | $11,450 | 55.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 38 | 257 | $25,700 | $11,080 | 43.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 101 | 101 | $27,775 | $9,962 | 35.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 49 | 49 | $37,734 | $7,813 | 20.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 63 | 63 | $49,421 | $6,600 | 13.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 58 | 60 | $31,497 | $4,281 | 13.6% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 21 | 45 | $23,760 | $3,596 | 15.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 44 | 44 | $8,800 | $3,125 | 35.5% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 57 | 62 | $12,860 | $3,016 | 23.4% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 17 | 89 | $8,900 | $2,979 | 33.5% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 16 | 82 | $7,790 | $2,841 | 36.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 53 | 54 | $4,050 | $1,881 | 46.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 59 | 59 | $7,670 | $1,814 | 23.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 17 | 18 | $14,058 | $1,796 | 12.8% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 19 | 19 | $9,326 | $1,061 | 11.4% |
| 76981 | Ultrasound scan of organ tissue for measuring elasticity | Office | 2023 | 20 | 20 | $3,880 | $976.71 | 25.2% |
| J3380 | Injection, vedolizumab, 1 mg | Office | 2022 | 15 | 15,600 | $546,000 | $270,895 | 49.6% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 76 | 798 | $55,860 | $25,714 | 46.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 201 | 251 | $40,160 | $20,279 | 50.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 115 | 116 | $122,304 | $19,687 | 16.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 86 | 458 | $45,800 | $19,181 | 41.9% |
About Dr. Michael Johnson, MD
Dr. Michael Johnson, MD is a Specialist healthcare provider based in Little Rock, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1134123813.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Johnson, MD has received a total of $18,114 in payments from pharmaceutical and medical device companies, with $3,706 received in 2024. These payments were reported across 959 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($17,936).
As a Medicare-enrolled provider, Johnson has provided services to 4,408 Medicare beneficiaries, totaling 30,542 services with total Medicare billing of $883,801. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Gastroenterology
- Location Little Rock, AR
- Active Since 06/09/2005
- Last Updated 12/12/2016
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1134123813
Products in Payments
- STELARA (Biological) $1,842
- RINVOQ (Biological) $1,528
- HUMIRA (Biological) $1,101
- Humira (Biological) $904.60
- XELJANZ (Drug) $886.16
- ENTYVIO (Biological) $871.25
- SKYRIZI (Biological) $765.39
- LINZESS (Drug) $690.43
- ZENPEP (Drug) $610.74
- ZEPOSIA (Drug) $605.36
- CREON (Drug) $592.42
- DUPIXENT (Biological) $526.41
- DIFICID (Drug) $427.72
- VIBERZI (Drug) $347.98
- Mavyret (Drug) $343.52
- VOQUEZNA (Drug) $335.12
- TREMFYA (Drug) $259.97
- REMICADE (Biological) $254.06
- GATTEX (Drug) $229.77
- Creon (Drug) $211.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Little Rock
Dr. Samuel Bledsoe, M.d, M.D
Specialist — Payments: $52,552
Dr. Scott Schlesinger, Md, MD
Specialist — Payments: $35,349
Dr. Joe Bradley, M.d, M.D
Specialist — Payments: $32,732
Dr. Brad Baltz, Md, MD
Specialist — Payments: $27,257
Dr. Joseph Beck, Md, MD
Specialist — Payments: $14,225
Dr. Rhonda Gentry, Md, MD
Specialist — Payments: $11,592